Key Market Indicators
Sales of hypnotic and sedative medicines in Latvia are expected to rise to $5.36 million by 2026. This is up 2% from the 2021 figure of $4.84 million. Since 2006, the Latvian market has seen an average annual growth rate of 8%. In 2021, Latvia was the 19th largest market for hypnotic and sedative medicines globally. Iceland was ranked first that year, with sales of $4.84 million. Germany, Sweden and Belgium took the next three spots, respectively.
